Practical aspects of insulin administration: what the healthcare provider knows

References

• Amod A, Coetzee A, Kinvig TE, et al. SEMSDA 2017 guidelines for the management of type 2 diabetes. J Endocrinol Metab Diabetes South Africa. 2017;22(1):S1–196.
   Google Scholar
• Cho NH, Shaw JE, Karuranga S, et al. IDF Diabetes atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018;138:271–281. https://doi.org/10.1016/j.diabres.2018.02.023.
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2014;37(SUPPL.1):81–90. https://doi.org/10.2337/dc08-s055.
   Google Scholar
• Crofford OB, Genuth S, Baker L. Diabetes control and complications trial (DCCT): Results of feasibility study. Diabetes Care. 1987;10(1):1–19. https://doi.org/10.2337/diacare.10.1.1.
   PubMed Web of Science ®Google Scholar
• Chrvala CA, Sherr D, Lipman RD. Diabetes self-management education for adults with type 2 diabetes mellitus: A systematic review of the effect on glycemic control. Patient Educ Couns. 2016;99(6):926–943. https://doi.org/10.1016/j.pec.2015.11.003.
   PubMed Web of Science ®Google Scholar
• Powers MA, Bardsley J, Cypress M, et al. Diabetes self-management education and support in type 2 diabetes: A joint position statement of the American Diabetes Association, the American Association of Diabetes educators, and the academy of nutrition and dietetics. Diabetes Educ. 2015;41(4):417–430. https://doi.org/10.1016/j.jand.2015.05.012.
   PubMed Web of Science ®Google Scholar
• Dube L, Van den Broucke S, Dhoore W, et al. An audit of diabetes self-management education programs in South Africa. J Public Health Res. 2015;4(3):176–184. https://doi.org/10.4081/jphr.2015.581.
   Google Scholar
• Dolinar R. The importance of good insulin injection practices in diabetes management. US Endocrinol. 2009;5(1):49–52. https://doi.org/10.17925/use.2009.05.1.49.
   Google Scholar
• Davel H, Berg GI, Allie R, et al. Injection technique guidelines for diabetes: sharp and to the point. J Endocrinol Metab Diabetes South Africa. 2014;19(1):8–13. https://doi.org/10.1080/16089677.2014.11073595.
   Google Scholar
• Karara MW, Otieno FC, Okalebo FA, et al. Determinants of insulin-related knowledge among healthcare providers at a county referral hospital in Kenya. Afr J Pharmacol Ther. 2016;5(2):74–80.
   Google Scholar
• Derr RL, Sivanandy MS, Bronich-Hall L, et al. Insulin-related knowledge among health care professionals in internal medicine. Diabetes Spectr. 2007;20(3):177–185. https://doi.org/10.2337/diaspect.20.3.177.
   Google Scholar
• Lee MKS, Liu Z, Quek TPL, et al. Insulin-related knowledge among health care professionals at a tertiary hospital. Diabetes Spectr. 2013;26(3):187–193. https://doi.org/10.2337/diaspect.26.3.187.
   Google Scholar
• Bain A, Kavanagh S, McCarthy S, Babar. Assessment of insulin-related knowledge among healthcare professionals in a large teaching Hospital in the United Kingdom. Pharmacy. 2019;7(1):7–16. https://doi.org/10.3390/pharmacy7010016
   Web of Science ®Google Scholar
• Van Zyl DG, Rheeder P. Survey on knowledge and attitudes regarding diabetic in patient management by medical and nursing staff at kalafong hospital. J Endocrinol Metab Diabetes South Africa. 2008;13(3):90–97. https://doi.org/10.1080/22201009.2008.10872178.
   Google Scholar
• Haque M, Navsa M, Emerson SH, et al. Barriers to initiating insulin therapy in patients with type 2 diabetes mellitus in public-sector primary health care centres in Cape Town. J Endocrinol Metab Diabetes South Africa. 2005;10(3):94–99. https://doi.org/10.1080/22201009.2005.10872127.
   Google Scholar
• Reach G, Pechtner V, Gentilella R, et al. Clinical inertia and its impact on treatment intensification in people with type 2 diabetes mellitus. Diabetes Metab. 2017;43(6):501–511. https://doi.org/10.1016/j.diabet.2017.06.003.
   PubMed Web of Science ®Google Scholar
• Cuddihy RM, Philis-Tsimikas A, Nazeri A. Type 2 Diabetes Care and insulin intensification. Diabetes Educ. 2011;37(1):111–123. https://doi.org/10.1177/0145721710388426.
   PubMed Web of Science ®Google Scholar
• Sunaert P, Willems S, Feyen L, et al. Engaging GPs in insulin therapy initiation: A qualitative study evaluating a support program in the Belgian context. BMC Fam Pract. 2014;15(1):1–9. https://doi.org/10.1186/1471-2296-15-144.
   PubMedGoogle Scholar
• Erzse A, Stacey N, Chola L, et al. The direct medical cost of type 2 diabetes mellitus in South Africa: a cost of illness study. Glob Health Action. 2019;12(1):1–8, https://doi.org/10.1080/16549716.2019.1636611.
   Web of Science ®Google Scholar
• Bahendeka S, Kaushik R, Swai AB, et al. EADSG guidelines: insulin storage and optimisation of injection technique in Diabetes management. Diabetes Ther. 2019;10(2):341–366. https://doi.org/10.1007/s13300-019-0574-x.
   PubMed Web of Science ®Google Scholar
• Kaiser P, Maxeiner S, Weise A, et al. Assessment of the mixing efficiency of neutral protamine hagedorn cartridges. J Diabetes Sci Technol. 2010;4(3):652–657. https://doi.org/10.1177/193229681000400320.
   PubMedGoogle Scholar
• Lucidi P, Porcellati F, Andreoli AM, et al. Pharmacokinetics and pharmacodynamics of NPH insulin in type 1 diabetes: The importance of appropriate resuspension before subcutaneous injection. Diabetes Care. 2015;38(12):2204–2210. https://doi.org/10.2337/dc15-0801.
   PubMed Web of Science ®Google Scholar
• Frid AH, Kreugel G, Grassi G, et al. New insulin delivery recommendations. Mayo Clin Proc. 2016;91(9):1231–1255. https://doi.org/10.1016/j.mayocp.2016.06.010.
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Insulin administration. Diabetes Care. 2003 Jan;26(suppl 1):s121–s124. https://doi.org/10.2337/diacare.27.2007.s106.
   PubMedGoogle Scholar
• Gibney MA, Arce CH, Byron KJ, et al. Skin and subcutaneous adipose layer thickness in adults with diabetes at sites used for insulin injections: implications for needle length recommendations. Curr Med Res Opin. 2010;26(6):1519–1530. https://doi.org/10.1185/03007995.2010.481203.
   PubMed Web of Science ®Google Scholar
• Koivisto VA, Felig P. Alterations in insulin absorption and in blood glucose control associated with varying insulin injection sites in diabetic patients. Ann Intern Med. 1980;92(1):59–61. https://doi.org/10.7326/0003-4819-92-1-59.
   PubMed Web of Science ®Google Scholar
• Annersten M, Frid A. Insulin pens dribble from the tip of the needle after injection. Pract Diabetes Int. 2000;17(4):109–111.
   Google Scholar
• Ginsberg BH, Parkes JL, Sparacino C. The kinetics of insulin administration by insulin pens. Horm Metab Res. 1994;26(12):584–587. https://doi.org/10.1055/s-2007-1001764.
   PubMed Web of Science ®Google Scholar
• Puder JJ, Atar M, Muller B, Pavan M, Keller U. Using insulin pen needles up to five times does not affect needle tip shape nor increase pain intensity. Diabetes Res Clin Pract. 2005;67(2):119–123. https://doi.org/10.1016/j.diabres.2004.06.001
   Google Scholar
• Blanco M, Hernández MT, Strauss KW, et al. Prevalence and risk factors of lipohypertrophy in insulin-injecting patients with diabetes. Diabetes Metab. 2013;39(5):445–453. https://doi.org/10.1016/j.diabet.2013.05.006.
   PubMedGoogle Scholar
• Canadian Diabetes Association. Forum for Injection Technique (FIT) Canada - Recommendations for Best Practice in Injection Technique 4th Edition 2020.Canada:CDA,2020. https://www.fit4diabetes.com/files/7816/0803/3133/FIT_Recommendations_2020.pdf (accessed 21 June 2020).
   Google Scholar